CytomX Therapeutics Inc Sustainability Reports
CytomX Therapeutics, Inc. is an oncology-focused biopharmaceutical company pioneering conditionally-activated antibody therapeutics. The company utilizes its proprietary Probody platform technology to design safer and more effective treatments localized to the tumor microenvironment.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493004VW2FW0QLL3345
FIGI: BBG001V0GS49
4 reports from 2016 to 2023
